Cell entry mechanisms of SARS-CoV-2

Shang, Jian, Wan, Yushun, Luo, Chuming, Ye, Gang, Geng, Qibin, Auerbach, Ashley, Li, Fang·2020·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.2003138117

Cited by (1,003)

Items 501–600 of 1,003

  1. Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
    Maria Gabriela Noval, Maria E. Kaczmarek, Akiko Koide, Bruno A. Rodriguez-Rodriguez, Ping Louie, Takuya Tada, Takamitsu Hattori, Tatyana Panchenko, Larizbeth A. Romero, Kai Wen Teng et al. · 2021 · Scientific Reports
  2. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
    Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, Jin‐Rong Zhou, S. M. Abdur Rahman, Isa Naina Mohamed · 2021 · Frontiers in Pharmacology
  3. A mini-review on the impact of COVID 19 on vital organs
    Muhammad Dawood Shah, Aini Simon Sumeh, Muhammad Abdullah Sheraz, Muthu Subash Kavitha, Balu Alagar Venmathi Maran, Kenneth Francis Rodrigues · 2021 · Biomedicine & Pharmacotherapy
  4. Roles of the polybasic furin cleavage site of spike protein in SARS‐CoV‐2 replication, pathogenesis, and host immune responses and vaccination
    Md. Golzar Hossain, Yan‐Dong Tang, Sharmin Akter, Chunfu Zheng · 2021 · Journal of Medical Virology
  5. Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
    Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, Mohammad Doroudian · 2022 · Reviews in Medical Virology
  6. Transition metal complexes as potential tools against SARS-CoV-2: an in silico approach
    Maynak Pal, Dulal Musib, Mithun Roy · 2020 · New Journal of Chemistry
  7. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives
    Roberta Giordo, Panagiotis Paliogiannis, Arduino Aleksander Mangoni, Gianfranco Pintus · 2021 · Vascular Biology
  8. Mechanical activation of spike fosters SARS-CoV-2 viral infection
    Wei Hu, Yong Zhang, Panyu Fei, Tongtong Zhang, Dan Yao, Yufei Gao, Jia Liu, Hui Chen, Lu Qiao, Tenny Mudianto et al. · 2021 · Cell Research
  9. Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress
    David Bracquemond, Delphine M. Muriaux · 2021 · mBio
  10. Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2
    Shuyuan Zhang, Qingtai Liang, Xinheng He, Chongchong Zhao, Wenlin Ren, Ziqing Yang, Ziyi Wang, Qiang Ding, Haiteng Deng, Tong Wang et al. · 2022 · Cell Research
  11. Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system
    Ryosuke Fujita, Masato Hino, Takeru Ebihara, Takumi Nagasato, Akitsu Masuda, Jae Man Lee, Tsuguru Fujii, Hiroaki Mon, Kohei Kakino, Ryo Nagai et al. · 2020 · Biochemical and Biophysical Research Communications
  12. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?
    Farshad Abedi, Ramin Rezaee, Andrew Wallace Hayes, Somayyeh Nasiripour, Gholamreza Karimi · 2020 · Cell Cycle
  13. Demyelination as a result of an immune response in patients with COVID-19
    Zahra Shabani · 2021 · Acta Neurologica Belgica
  14. Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
    Mirjam Kiener, Nuria Roldán, Carlos Machahua, Arunima Sengupta, Thomas Geiser, Olivier T. Guenat, Manuela Funke-Chambour, Nina Hobi, Marianna Kruithof‐de Julio · 2021 · Frontiers in Medicine
  15. Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor
    Elhan Taka, Sema Zeynep Yilmaz, Mert Gölcük, Ceren Kılınç, Umut Aktas, Ahmet Yıldız, Mert Gür · 2021 · The Journal of Physical Chemistry B
  16. Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality
    Yadira Palacios, Andy Ruíz, Lucero A. Ramón‐Luing, Ranferi Ocaña‐Guzmán, Omar Barreto-Rodríguez, Anahí Sánchez-Monciváis, Brenda Tecuatzi-Cadena, Ana Gabriela Regalado-García, Rey David Pineda-Gudiño, Alicia García-Martínez et al. · 2021 · International Journal of Molecular Sciences
  17. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants
    Ching‐Wen Chang, Krishna Mohan Parsi, Mohan Somasundaran, Emma Vanderleeden, John Cruz, Alyssa Cousineau, Ping Liu, Qi Li, Yang Wang, René Maehr et al. · 2022 · Viruses
  18. The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells
    Christopher B. Forsyth, Lijuan Zhang, Abhinav Bhushan, Barbara A. Swanson, Li Zhang, João I. Mamede, Robin M. Voigt, Maliha W. Shaikh, Phillip A. Engen, Ali Keshavarzian · 2022 · Microorganisms
  19. Insight into the role of clathrin‐mediated endocytosis inhibitors in SARS‐CoV‐2 infection
    Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Soumya Bikash Ghosh, Samah A. Loutfy, Sara Samy Elkafas, Nasra F. Abdel Fattah, Mohamed Hessien · 2022 · Reviews in Medical Virology
  20. The SARS-CoV-2 spike protein binds and modulates estrogen receptors
    Óscar Solís, Andrea R. Beccari, Daniela Iaconis, Carmine Talarico, Camilo A. Ruiz-Bedoya, Jerome C. Nwachukwu, Annamaria Cimini, Vanessa Castelli, Riccardo Bertini, Monica Montopoli et al. · 2022 · Science Advances
  21. Circulating microRNAs as emerging regulators of COVID-19
    Yulong Liang, Dan Fang, Xiaojun Gao, Xin Deng, Ni Chen, Jianbo Wu, Min De ZENG, Mao Luo · 2022 · Theranostics
  22. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
    Lin Wang, Ye Xiang · 2020 · Viruses
  23. COVID-19: Molecular and Cellular Response
    Shamila D. Alipoor, Esmaeil Mortaz, Hamidreza Jamaati, Payam Tabarsi, Hasan Bayram, Mohammad Varahram, Ian Michael Adcock · 2021 · Frontiers in Cellular and Infection Microbiology
  24. Effect of Biomedical Materials in the Implementation of a Long and Healthy Life Policy
    L. A. Dobrzański, Anna Danuta Dobrzańska-Danikiewicz, Lech B. Dobrzański · 2021 · Processes
  25. Why All the Fury over Furin?
    Essam Eldin A. Osman, Alnawaz Rehemtulla, Nouri Neamati · 2021 · Journal of Medicinal Chemistry
  26. Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection
    Samsara W. Upadhya, Jalees Rehman, Asrar B. Malik, Shuibing Chen · 2021 · Physiology
  27. Ultrastructural insight into SARS-CoV-2 entry and budding in human airway epithelium
    Andreia Pinto, Ranjit Rai, Jonathan C. Brown, Paul Griffin, James R. Edgar, Anand Shah, Aran Singanayagam, Claire L. Hogg, William Barclay, Clare E. Futter et al. · 2022 · Nature Communications
  28. Advancement in biosensors for inflammatory biomarkers of SARS-CoV-2 during 2019–2020
    Mayank Garg, Amit L. Sharma, Suman B. Singh · 2020 · Biosensors and Bioelectronics
  29. Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
    Nabab Khan, Xuesong Chen, Jonathan D. Geiger · 2020 · Frontiers in Pharmacology
  30. Context contribution to the intermolecular recognition of human ACE2-derived peptides by SARS-CoV-2 spike protein: implications for improving the peptide affinity but not altering the peptide specificity by optimizing indirect readout
    Peng Zhou, Heyi Wang, Zheng Chen, Qian Liu · 2020 · Molecular Omics
  31. SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
    Christopher J. Coke, Brandon Davison, Niariah Fields, Jared Fletcher, Joseph Rollings, Leilani Roberson, Kishore B. Challagundla, Chethan Sampath, James Cade, Cherae M. Farmer‐Dixon et al. · 2021 · Journal of Clinical Medicine
  32. The Physiological Mechanisms of the Sex-Based Difference in Outcomes of COVID19 Infection
    Susan Wray, Sarah Arrowsmith · 2021 · Frontiers in Physiology
  33. IL-6 modulation for COVID-19: the right patients at the right time?
    Paolo A. Ascierto, Binqing Fu, Haiming Wei · 2021 · Journal for ImmunoTherapy of Cancer
  34. Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
    Ann Z. Bauer, Rebecca J Gore, Susan R Sama, Richard Rosiello, Lawrence Garber, Devi Sundaresan, Anne McDonald, Patricia Arruda, David Kriebel · 2020 · Journal of Clinical Hypertension
  35. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
    André E. Nel, Jeff F. Miller · 2021 · ACS Nano
  36. Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction
    Changdong Lin, Yue Li, MengYa Yuan, Mengwen Huang, Cui Liu, Chenjian Gu, Xingchao Pan, YaTing Wen, Xinyi Xu, Chenqi Xu et al. · 2021 · Signal Transduction and Targeted Therapy
  37. Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19
    Antonio Vitiello, Francesco Ferrara · 2020 · Life Sciences
  38. Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review
    Rami A. Al‐Horani, Srabani Kar · 2020 · Viruses
  39. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
    Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, Matin Fathollahi, Hadi Hossainpour, Amirhooshang Alvandi, Jale Moradi, Ramin Abiri · 2021 · International Immunopharmacology
  40. RETRACTED: SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro
    Hui Jiang, Ya-Fang Mei · 2021 · Viruses · Retracted
  41. MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
    Mamta Panda, Elora Kalita, Satyendra Singh, Ketan Kumar, Abhishek Rao, Vijay Kumar Prajapati · 2022 · Life Sciences
  42. In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
    Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, Sadia Afsana Mim, Md. Saidur Rahaman, Talha Bin Emran, Esra Küpeli Akkol, Rohit Sharma, Fahad Abdulrahman Alhumaydhi, Sherouk Hussein Sweilam et al. · 2022 · Frontiers in Cellular and Infection Microbiology
  43. Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant
    Wei Zhang, Ke Shi, Qibin Geng, Gang Ye, Hideki Aihara, Fang Li · 2022 · Proceedings of the National Academy of Sciences
  44. Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants
    Haonan Yang, Huimin Guo, Aojie Wang, Liwei Cao, Qing Fan, Jie Jiang, Miao Wang, Lin Lin, Xiangyang Ge, Haiyan Wang et al. · 2024 · Nature Communications
  45. Structural Basis of SARS-CoV-2– and SARS-CoV–Receptor Binding and Small-Molecule Blockers as Potential Therapeutics
    Hariharan Sivaraman, Shi Yin Er, Yeu Khai Choong, Edem Gavor, Jayaraman Sivaraman · 2020 · The Annual Review of Pharmacology and Toxicology
  46. An Overview of the Crystallized Structures of the SARS-CoV-2
    Mihaela Ileana Ionescu · 2020 · The Protein Journal
  47. Non-Coding RNAs and SARS-Related Coronaviruses
    Hanna Henzinger, Dominik Andreas Barth, Christiane Klec, Martin Pichler · 2020 · Viruses
  48. Susceptibility to COVID-19 in Pregnancy, Labor, and Postpartum Period: Immune System, Vertical Transmission, and Breastfeeding
    Adson José Martins Vale, Amélia Carolina Lopes Fernandes, Fausto Pierdoná Gúzen, Francisco Irochima Pinheiro, Eduardo Pereira de Azevedo, Ricardo Ney Cobucci · 2021 · Frontiers in Global Women s Health
  49. Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs
    Caitlin I. Stoddard, Jared Galloway, Helen Y. Chu, Mackenzie M. Shipley, Kevin Sung, Hannah L. Itell, Caitlin R. Wolf, Jennifer K. Logue, Ariana Magedson, Meghan E. Garrett et al. · 2021 · Cell Reports
  50. An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
    Trina Ekawati Tallei, Fatimawali Fatimawali, Afriza Yelnetty, Rinaldi Idroes, Diah Kusumawaty, Talha Bin Emran, Talha Z. Yesiloglu, Wolfgang Sippl, Shafi Mahmud, Taha Alqahtani et al. · 2021 · Frontiers in Pharmacology
  51. Computational Investigations for Identification of Bioactive Molecules from Baccaurea ramiflora and Bergenia ciliata as Inhibitors of SARS-CoV-2 Mpro
    James H. Zothantluanga, Mohnad Abdalla, Mithun Rudrapal, Qiang Tian, Dipak Chetia, Jin Li · 2022 · Polycyclic aromatic compounds
  52. COVID-19 pandemic: Can zinc supplementation provide an additional shield against the infection?
    Mohammed Shawkat Razzaque · 2021 · Computational and Structural Biotechnology Journal
  53. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline
    Jeffrey D. Pyne, Adam M. Brickman · 2021 · Neurodegenerative Diseases
  54. Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2
    Tomokazu Ohishi, Takayuki Hishiki, Mirza S. Baig, Sajjan Rajpoot, Uzma Saqib, Tomohiko Takasaki, Yukihiko Hara · 2022 · PLoS ONE
  55. Diagnostic and therapeutic potential of protease inhibition
    Natalia Ćwilichowska, Karolina Weronika Świderska, Agnieszka Dobrzyń, Marcin Drąg, Marcin Poręba · 2022 · Molecular Aspects of Medicine
  56. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery
    Qian Lu, Julia TCW · 2021 · International Journal of Molecular Sciences
  57. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity
    Szu‐Wei Huang, Sheng‐Fan Wang · 2021 · International Journal of Molecular Sciences
  58. Genetic variability in COVID-19-related genes in the Brazilian population
    Rodrigo Secolin, Tânia Kawasaki de Araujo, Marina C. Gonsales, Cristiane S. Rocha, Michel Satya Naslavsky, Luiz Armando De Marco, Maria Aparecida Camargos Bicalho, Vinícius de Lima Vazquez, Mayana Zatz, Wilson A. Silva et al. · 2021 · Human Genome Variation
  59. Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
    Yanmei Hu, Hyunil Jo, William F. DeGrado, Jun Wang · 2022 · Journal of Medical Virology
  60. Drug Repurposing Screens Reveal FDA Approved Drugs Active Against SARS-CoV-2
    Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Elisha Segrist, Minghua Li, Kellie A. Jurado, Kirandeep Samby, Holly R. Ramage, D. Schultz, Sara R. Cherry · 2020 · SSRN Electronic Journal
  61. Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations
    Helms, Louisa, Marchiano, Silvia, Stanaway, Ian B., Hsiang, Tien-Ying, Juliar, Benjamin A., Saini, Shally, Zhao, Yan Ting, Khanna, Akshita, Menon, Rajasree, Alakwaa, Fadhl et al. · 2021 · JCI Insight
  62. How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis
    Fabio Panariello, Lorenzo Cellini, Maurizio Speciani, Diana De Ronchi, Anna Rita Atti · 2020 · Frontiers in Psychiatry
  63. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
    Ирина Анатольевна Ленева, Карташова Надежда Павловна, А. А. Поромов, Anastasiia V. Gracheva, E. R. Korchevaya, Глубокова Екатерина Андреевна, Olga V. Borisova, Штро Анна Андреевна, S. Ya. Loginova, Щукина Вероника Николаевна et al. · 2021 · Viruses
  64. Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers
    Evgeny N. Knyazev, Stepan A. Nersisyan, Alexander Tonevitsky · 2021 · Frontiers in Immunology
  65. Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core
    Alexander J. Pak, Alvin Yu, Zunlong Ke, John A. G. Briggs, Gregory A. Voth · 2022 · Nature Communications
  66. High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein
    Ibrahim E. Awad, Abd Al‐Aziz A. Abu‐Saleh, Sweta Sharma, Arpita Yadav, Raymond A. Poirier · 2020 · Journal of Biomolecular Structure and Dynamics
  67. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system
    Qingyuan Zhu, Yaling Zhang, Li Wang, Xiangyu Yao, Daitze Wu, Junjun Cheng, Xiaoyu Pan, Haixia Liu, Zhipeng Yan, Lu Gao · 2021 · Antiviral Research
  68. The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease
    Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi · 2021 · Molecular Neurobiology
  69. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein
    Mizuki Yamamoto, Jin Gohda, Ayako Kobayashi, Keiko Tomita, Youko Hirayama, Naohiko Koshikawa, Motoharu Seiki, Kentaro Semba, Tetsu Akiyama, Yasushi Kawaguchi et al. · 2022 · mBio
  70. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
    Guoli Shi, Abhilash I. Chiramel, Tiansheng Li, Kin Kui Lai, Adam D. Kenney, Ashley Zani, Adrian C. Eddy, Saliha Majdoul, Lizhi Zhang, Tirhas Dempsey et al. · 2022 · Journal of Clinical Investigation
  71. Functional immune mapping with deep-learning enabled phenomics applied to immunomodulatory and COVID-19 drug discovery
    Michael F. Cuccarese, Berton A. Earnshaw, Katie Heiser, Ben Fogelson, Chadwick T. Davis, Peter McLean, Hannah B. Gordon, Kathleen-Rose Skelly, Fiona L. Weathersby, Vlad Rodic et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells
    Sayed Ausim Azizi, Saara‐Anne Azizi · 2020 · Journal of NeuroVirology
  73. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
    Mai Mohamed Abdelmoaty, Pravin Yeapuri, Jatin Machhi, Katherine E. Olson, Farah Shahjin, Vikas S. Kumar, You Zhou, Jingjing Liang, Kabita Pandey, Arpan Acharya et al. · 2021 · Frontiers in Immunology
  74. SARS-CoV-2 hijacks macropinocytosis to facilitate its entry and promote viral spike–mediated cell-to-cell fusion
    Yuyuan Zhang, Ronghui Liang, Shujie Wang, Zi‐Wei Ye, Tong-Yun Wang, Meng Chen, Jianbo Liu, Na Lei, Yuelin Yang, Yongbo Yang et al. · 2022 · Journal of Biological Chemistry
  75. In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters
    Yuri Furusawa, Maki Kiso, Shun Iida, Ryuta Uraki, Yuichiro Hirata, Masaki Imai, Tadaki Suzuki, Seiya Yamayoshi, Yoshihiro Kawaoka · 2023 · EBioMedicine
  76. Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication
    Yi Zhang, Liang V. Tang · 2020 · Journal of Proteome Research
  77. Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity
    Prem Rajak, Abhratanu Ganguly, Saurabh Sarkar, Moutushi Mandi, Moumita Dutta, Sayanti Podder, Salma Khatun, Sumedha Roy · 2021 · Food and Chemical Toxicology
  78. Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection
    Byoung Kwon Park, Dongbum Kim, Sangkyu Park, Sony Maharjan, Jin-Soo Kim, Jun-Kyu Choi, Madhav Akauliya, Younghee Lee, Hyung‐Joo Kwon · 2021 · Biomolecules & Therapeutics
  79. Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without
    Samuel A. Theuerkauf, Alexander Michels, Vanessa Riechert, Thorsten J. Maier, Egbert Flory, Klaus Cichutek, Christian J. Buchholz · 2021 · iScience
  80. High-Throughput Screening for Drug Discovery
    Shailendra Kumar Saxena · 2021 · IntechOpen eBooks
  81. Protective neutralizing epitopes in SARS‐CoV‐2
    Hejun Liu, Ian A. Wilson · 2022 · Immunological Reviews
  82. Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019
    Rafael Ludemann Camargo, Bruna Bombassaro, Milena Monfort‐Pires, Eli Mansour, André C. Palma, Luciana C. Ribeiro, Raisa Gusso Ulaf, Ana Flávia Bernardes, Thyago A. Nunes, Marcus Vinicius Rodrigues de Agrela et al. · 2022 · Frontiers in Cardiovascular Medicine
  83. Effect of COVID-19 on liver abnormalities: a systematic review and meta‐analysis
    Khalid Ibrahim Bzeizi, Maheeba Abdulla, Nafeesa Mohammed, Jehad AlQamish, Negar Jamshidi, Dieter Broering · 2021 · Scientific Reports
  84. Mutational analysis of structural proteins of SARS-CoV-2
    Shweta Jakhmola, Omkar Indari, Dharmendra Kashyap, Nidhi Varshney, Ayan Das, Elangovan Manivannan, Hem Chandra Jha · 2021 · Heliyon
  85. Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19
    Kevin E. Kip, Erin K McCreary, Kevin Collins, Tami E. Minnier, Graham M. Snyder, William Garrard, Jeffrey C. McKibben, Donald M. Yealy, Christopher W. Seymour, David T. Huang et al. · 2023 · Annals of Internal Medicine
  86. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
    Cristina Cerqueira Vieira, Lucas Nery, Ludimila de Barcelos Ubaldo Martins, Luiz Gustavo Pessoa Pires Jabour, Raphael Figuiredo Dias, Ana Cristina Simões e Silva · 2020 · Current Drug Targets
  87. The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
    Michael D. Knierman, Megan B. Lannan, Laura J. Spindler, Carl L. McMillian, Robert J. Konrad, Robert W. Siegel · 2020 · Cell Reports
  88. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations
    Sugunadevi Sakkiah, Wenjing Guo, Bohu Pan, Zuowei Ji, Gökhan Yavaş, Marli S.P. Azevedo, Jessica J. Hawes, Tucker A. Patterson, Huixiao Hong · 2021 · Frontiers in Chemistry
  89. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019
    Suzane Ramos da Silva, Enguo Ju, Wen Meng, Alberto E. Paniz Mondolfi, Sanja Đačić, Anthony Richard Green, Clare Bryce, Zachary Grimes, Mary Elizabeth Fowkes, Emilia Mia Sordillo et al. · 2021 · The Journal of Infectious Diseases
  90. Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors
    Gangan Yan, Dongsheng Li, Yuan Lin, Zhenghao Fu, Haiyan Qi, Xiaoping Liu, Jing Zhang, Shuyi Si, Yunyu Chen · 2021 · Cell & Bioscience
  91. Plant‐based expression and characterization of SARS‐CoV‐2 virus‐like particles presenting a native spike protein
    Jae‐Wan Jung, Gergana Zahmanova, Ivan Nikiforov Minkov, George P. Lomonossoff · 2022 · Plant Biotechnology Journal
  92. Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
    Enya Qing, Pengfei Li, Laura M. Cooper, Sebastian R. Schulz, Hans‐Martin Jäck, Lijun Rong, Stanley M. Perlman, Tom Gallagher · 2022 · Cell Reports
  93. Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
    Mariana F. Tioni, Robert Jordan, Angie Silva Pena, Aditya Garg, Danlu Wu, Shannon I. Phan, Christopher M. Weiss, Xing Cheng, Jack J. Greenhouse, Tatyana Orekov et al. · 2022 · npj Vaccines
  94. Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron
    Mehdi Benlarbi, Geneviève Laroche, Corby Fink, Kathy Fu, Rory P. Mulloy, Alexandra Phan, Ardeshir Ariana, Corina M. Stewart, Jérémie Prévost, Guillaume Beaudoin-Bussières et al. · 2022 · iScience
  95. Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain
    Aristotelis Antonopoulos, Steven Broome, Victor S. Sharov, Christopher Ziegenfuss, Richard L. Easton, Maria Panico, Anne Dell, Howard R. Morris, Stuart M. Haslam · 2020 · Glycobiology
  96. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
    Bülent Kantarcıoğlu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio A. Lievano, Alfonso Javier Tafur, Eduardo Ramacciotti et al. · 2021 · Clinical and Applied Thrombosis/Hemostasis
  97. Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity
    Anwar Mohammad, Jehad Ahmed Abubaker, Fahd Al‐Mulla · 2021 · Virus Research
  98. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
    Md Minhas Hossain Sakib, Aktiya Anjum Nishat, Mohammad Tarequl Islam, Mohammad Abu Raihan Uddin, Md Shahriar Iqbal, Farhan Fuad Bin Hossen, Mohammad Imran Ahmed, Md Samiul Bashir, Takbir Hossain, Umma Sumia Tohura et al. · 2021 · Computers in Biology and Medicine
  99. The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19
    Yadong Gao, Ioana Octavia Agache, Mübeccel Akdiş, Kari Christine Nadeau, Ludger Klimek, Marek Jutel, Cezmi A. Akdiş · 2021 · International Immunology
  100. Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study
    Stefania Mazzini, Loana Musso, Sabrina Dallavalle, Roberto Artali · 2020 · Molecules